Douglas E. Linn

2.0k total citations · 1 hit paper
17 papers, 1.5k citations indexed

About

Douglas E. Linn is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Douglas E. Linn has authored 17 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Douglas E. Linn's work include Prostate Cancer Treatment and Research (10 papers), Cancer Mechanisms and Therapy (5 papers) and Peptidase Inhibition and Analysis (4 papers). Douglas E. Linn is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Cancer Mechanisms and Therapy (5 papers) and Peptidase Inhibition and Analysis (4 papers). Douglas E. Linn collaborates with scholars based in United States, United Kingdom and Canada. Douglas E. Linn's co-authors include Yun Qiu, Feng Sun, Jonathan Melamed, Richeng Jiang, Xi Yang, Hegang Chen, Hege Chen, Xiangtian Kong, Zhiyong Guo and Joanne Edwards and has published in prestigious journals such as Journal of Biological Chemistry, Genes & Development and PLoS ONE.

In The Last Decade

Douglas E. Linn

17 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion–Resistant Growth

2009 698 citations Zhiyong Guo, Xi Yang et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Douglas E. Linn United States	11	953	847	379	334	249	17	1.5k
Beth E. Helgeson United States	6	1.3k 1.4×	1.2k 1.4×	660 1.7×	252 0.8×	119 0.5×	7	2.0k
Susan Korenchuk United States	13	462 0.5×	896 1.1×	204 0.5×	348 1.0×	93 0.4×	18	1.4k
Joan Bolt‐de Vries Netherlands	20	405 0.4×	508 0.6×	598 1.6×	591 1.8×	231 0.9×	34	1.4k
Daniel P. Rakiec Switzerland	9	454 0.5×	572 0.7×	223 0.6×	178 0.5×	119 0.5×	11	1.0k
Hidetoshi Kuruma Japan	19	650 0.7×	544 0.6×	225 0.6×	257 0.8×	94 0.4×	41	1.1k
Patrick J. Grohar United States	19	623 0.7×	1.1k 1.3×	234 0.6×	444 1.3×	65 0.3×	45	1.7k
Armelle Degeorges France	18	404 0.4×	747 0.9×	562 1.5×	776 2.3×	95 0.4×	34	1.6k
María G. Kuba United States	14	445 0.5×	897 1.1×	370 1.0×	773 2.3×	69 0.3×	20	1.5k
Katharine Ellwood‐Yen United States	8	531 0.6×	787 0.9×	287 0.8×	336 1.0×	37 0.1×	10	1.3k
Umesh Bhanot United States	18	499 0.5×	1.0k 1.2×	678 1.8×	704 2.1×	58 0.2×	44	1.9k

Countries citing papers authored by Douglas E. Linn

Since Specialization

Citations

This map shows the geographic impact of Douglas E. Linn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas E. Linn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas E. Linn more than expected).

Fields of papers citing papers by Douglas E. Linn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas E. Linn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas E. Linn. The network helps show where Douglas E. Linn may publish in the future.

Co-authorship network of co-authors of Douglas E. Linn

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas E. Linn. A scholar is included among the top collaborators of Douglas E. Linn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas E. Linn. Douglas E. Linn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Wiswell, Derek, Edward P. Bowman, Douglas E. Linn, et al.. (2020). A capillary electrophoresis based approach for the identification of anti-drug antibodies against camelid VHH biologics (Nanobodies®). Journal of Pharmacological and Toxicological Methods. 103. 106872–106872. 8 indexed citations

Pakula, Hubert, et al.. (2018). Protocols for Studies on TMPRSS2/ERG in Prostate Cancer. Methods in molecular biology. 1786. 131–151. 1 indexed citations

Barros‐Silva, João D., Douglas E. Linn, Guoji Guo, et al.. (2018). Single-Cell Analysis Identifies LY6D as a Marker Linking Castration-Resistant Prostate Luminal Cells to Prostate Progenitors and Cancer. Cell Reports. 25(12). 3504–3518.e6. 64 indexed citations

Miselis, Nathan R., Douglas E. Linn, Clifford R. Restaino, et al.. (2017). Abstract 577: Antagonism of the co-inhibitory receptor BTLA enhances efficacy of anti-PD-1 treatment in murine syngeneic tumor models. Cancer Research. 77(13_Supplement). 577–577. 5 indexed citations

Linn, Douglas E., et al.. (2016). Deletion of Interstitial Genes between TMPRSS2 and ERG Promotes Prostate Cancer Progression. Cancer Research. 76(7). 1869–1881. 27 indexed citations

Linn, Douglas E., et al.. (2015). Genetic Interaction between Tmprss2-ERG Gene Fusion and Nkx3.1-Loss Does Not Enhance Prostate Tumorigenesis in Mouse Models. PLoS ONE. 10(3). e0120628–e0120628. 5 indexed citations

Baena, Esther, Zhen Shao, Douglas E. Linn, et al.. (2013). ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients. Genes & Development. 27(6). 683–698. 139 indexed citations

Natarajan, Karthika, Yingqiu Xie, Mehmet Burcu, et al.. (2013). Pim-1 Kinase Phosphorylates and Stabilizes 130 kDa FLT3 and Promotes Aberrant STAT5 Signaling in Acute Myeloid Leukemia with FLT3 Internal Tandem Duplication. PLoS ONE. 8(9). e74653–e74653. 59 indexed citations

Linn, Douglas E., Xi Yang, Yingqiu Xie, et al.. (2013). Abstract 4089: Differential regulation of androgen receptor by PIM-1 kinases via phosphorylation-dependent recruitment of distinct ubiquitin E3 ligases.. Cancer Research. 73(8_Supplement). 4089–4089. 4 indexed citations

10.

Linn, Douglas E., Xi Yang, Yingqiu Xie, et al.. (2012). Differential Regulation of Androgen Receptor by PIM-1 Kinases via Phosphorylation-dependent Recruitment of Distinct Ubiquitin E3 Ligases. Journal of Biological Chemistry. 287(27). 22959–22968. 51 indexed citations

11.

Dai, Bojie, Hege Chen, Shengjie Guo, et al.. (2010). Compensatory Upregulation of Tyrosine Kinase Etk/BMX in Response to Androgen Deprivation Promotes Castration-Resistant Growth of Prostate Cancer Cells. Cancer Research. 70(13). 5587–5596. 53 indexed citations

12.

Xie, Yingqiu, Mehmet Burcu, Douglas E. Linn, Yun Qiu, & Maria R. Baer. (2010). Pim-1 Kinase Protects P-Glycoprotein from Degradation and Enables Its Glycosylation and Cell Surface Expression. Molecular Pharmacology. 78(2). 310–318. 76 indexed citations

13.

Linn, Douglas E., Feng Sun, Yuancai Xie, et al.. (2010). A Role for OCT4 in Tumor Initiation of Drug-Resistant Prostate Cancer Cells. Genes & Cancer. 1(9). 908–916. 83 indexed citations

14.

Guo, Zhiyong, Xi Yang, Feng Sun, et al.. (2009). A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion–Resistant Growth. Cancer Research. 69(6). 2305–2313. 698 indexed citations breakdown →

15.

Xu, Kexin, Hermela Shimelis, Douglas E. Linn, et al.. (2009). Regulation of Androgen Receptor Transcriptional Activity and Specificity by RNF6-Induced Ubiquitination. Cancer Cell. 15(4). 270–282. 183 indexed citations

16.

Zhang, Yuexing, Douglas E. Linn, Zhenqiu Liu, et al.. (2008). EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance. Molecular Cancer Therapeutics. 7(10). 3176–3186. 51 indexed citations

17.

Xie, Yingqiu, Kexin Xu, Douglas E. Linn, et al.. (2007). The 44-kDa Pim-1 Kinase Phosphorylates BCRP/ABCG2 and Thereby Promotes Its Multimerization and Drug-resistant Activity in Human Prostate Cancer Cells. Journal of Biological Chemistry. 283(6). 3349–3356. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact